Close

Press Releases

Amcor Flexibles celebrates a dynamic DESICCANT decade at Pharmapack 2017

Amcorโ€™s patented Dessiflex Blister System has been adopted by some of the worldโ€™s largest pharma manufacturers.Amcor Flexibles, a world leader in flexible packaging for the pharmaceutical sector, will celebrate a major milestone on the occasion of Pharmapack 2017. ...

AbbVie, Genomics Medicine Ireland and WuXi NextCODE Announce Landmark Population Genomics Alliance

AbbVie , a global biopharmaceutical company, life-sciences startup Genomics Medicine Ireland Limited (GMI), and WuXi NextCODE, the global contract genomics organization announced the launch of a long-term strategic alliance to conduct population genomics research in Ireland aimed at advancing...

Global pharma players trust in Swisslog to strengthen intralogistics

Swisslog, a leading automation expert for robot-based and data driven intralogistic solutions, has completed the latest expansion of the high-bay warehouse for healthcare manufacturers. B.Braun Melsungen. In addition to this, pharmaceutical company and long-term Swisslog customer,...

ContraVir Pharmaceuticals awarded grant from NRC to advance CRV431

ContraVir Pharmaceuticals, Inc a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies announced that the company was awarded a $297,875 CAD research grant from the National Research Council in Canada through the Council's Industrial Research...

Ardelyx begins two trials for RDX7675 for hyperkalemia treatment

Ardelyx, Inc. a clinical-stage company focused on enhancing the treatment of patients with gastrointestinal and cardiorenal diseases announced the initiation of a Phase 3 clinical trial and an onset-of-action clinical trial evaluating RDX7675 in patients with hyperkalemia, a potentially...

Natco Pharma unveils generic version of Hepatitis C drug in Nepal

NATCO launches VELPANAT in Nepal- 1st generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination medicine in the country. Natco Pharma Limited announced that it has launched the first generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed...

ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders,announced the start of two phase III studies designed to evaluate an investigational long-acting,injectable regimen of cabotegravir (ViiV Healthcare) and rilpivirine...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป